TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/10/24 16:16 | 10/8/24 | RVMD | Revolution Medicines, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Weber Barbara | CA | D | S | -250 | 48.02 | 0 | -5 | -28 | 13 | D | |||||||||||||||
2/8/24 21:14 | 2/6/24 | TNGX | Tango Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Weber Barbara | MA | DO | CEO | S.m | -115 | 12.59 | 0 | -9 | -1 | 1,535 | D | ||||||||||||||
9/6/23 20:03 | 9/1/23 | RVMD | Revolution Medicines, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Weber Barbara | CA | D | M.d | 57 | 3.80 | 0 | 15 | 999% | 16 | D | |||||||||||||||
9/6/23 20:03 | 9/1/23 | RVMD | Revolution Medicines, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Weber Barbara | CA | D | S.d | -526 | 35.07 | 0 | -15 | -49 | 16 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |